The Life Raft Group is committed to enhancing the survival and quality of life for people living with Gastrointestinal Stromal Tumor (GIST), and other rare diseases, through patient-powered research, education and empowerment, and global advocacy efforts.
Other Programs Supported by The Life Raft Group:
Real World Evidence In Action
Traditional models for cancer research have resulted in many breakthrough treatments for patients, but it is not enough. The LRG’s approach to GIST research through real world evidence, relies on timely, accurate data from the patient’s perspective, with patient survival as the primary objective.
RECENT LRG DATA
Update your Patient Registry Info.
Join The Life Raft Group.
Current GIST Clinical Trials.
Search the GIST Specialist Database.
HELP US SAVE LIVES
The Life Raft Group is a community and it is up to all of us to make a difference. There are many ways to help. We always need patient tissue and data in our GIST patient registry. Volunteering your time or making a monetary donation also helps us drive research forward and save lives.
News
“Water of Life” Will Flow at LRG Event
The Water of Life event is the first annual whisky fundraiser hosted by LRG member, Dr. Mathew J. Lurin (co-founder of [...]
Advocacy in Chile Moves Forward: an Update
New steps have been taken in Chile that will benefit patients who need high cost treatments. Piga Fernández, LRG Global Consultant [...]
LRG State Leaders Connect in First Virtual Meeting
On Wednesday, February 11, the Life Raft Group’s state leaders had their first opportunity to gather virtually and to discuss the [...]
Cancerversary: Pat Berg
I had a “surprise” diagnosis of GIST in April, 2009, and thanks to the Life Raft Group and its knowledge and [...]
Conditional Disease-free Survival after GIST Resection Improves Over Time
In a recent study led by Danielle A Bischof, MD of Johns Hopkins and published in JAMA Surgery, the authors propose a [...]
Future NCCN Guidelines to Include Evidence Blocks
A recent roundtable discussion at the National Comprehensive Cancer Network’s (NCCN) 20th Annual Conference opened up a discussion on treatment costs [...]
Cancer Survivors and Heart Health
Cancer patients are surviving longer thanks to breakthrough treatments like targeted therapies. With the additional longevity, however, is the responsibility to [...]
Phase II Clinical Trial in Australia
A Phase II clinical trial comparing Imatinib alternated with Regorafenib to Imatinib alone is currently underway and recruiting in Australia. The trial, [...]





























